Analysts at Barclays Capital raised their price objective on shares of Cemex SAB de CV (NYSE:CX) from $12.00 to $13.00 in a research report issued to clients and investors on Friday, Analyst Ratings.Net reports. The firm currently has an “overweight” rating on the stock. Barclays Capital’s price target points to a potential upside of 9.24% from the company’s current price.
A number of other firms have also recently commented on CX. Analysts at UBS AG upgraded shares of Cemex SAB de CV from a “neutral” rating to a “buy” rating in a research note to investors on Thursday, July 25th. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of Cemex SAB de CV in a research note to investors on Wednesday, July 10th. They now have a $12.30 price target on the stock, down previously from $12.60. Finally, analysts at Morgan Stanley upgraded shares of Cemex SAB de CV from an “equal weight” rating to an “overweight” rating in a research note to investors on Tuesday, June 25th.
Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $12.25.
Cemex SAB de CV (NYSE:CX) traded up 1.01% on Friday, hitting $12.02. Cemex SAB de CV has a 1-year low of $6.8846 and a 1-year high of $12.57. The stock’s 50-day moving average is currently $10.85. The company’s market cap is $13.664 billion.
CEMEX SAB de CV (NYSE:CX) is a Mexico-based company principally engaged, through its subsidiaries, in the cement manufacturing.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.